-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Qiaozhi Wei1* and Paul S. Frenette, MD2

1Albert Einstein College of Medicine, Bronx, NY
2Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY

Don M. Wojchowski, PhD1, Edward Jachimowicz1*, Ruth Asch2* and Nicole M. Rainville2*

1COBRE Center of Excellence in Stem & Progenitor Cell Biology and Regenerative Medicine, Maine Medical Center Research Institute, Scarborough, ME
2Maine Medical Center Research Institute, Scarborough, ME

Betsabeh Khoramian Tusi, Ph.D.*, Daniel Hidalgo, MA* and Merav Socolovsky, MBBS, PhD

Dept. of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA

Nobuto Arashiki, PhD1*, Yuichi Takakuwa, MD, PhD1*, Hiromi Ogura, MD, PhD2*, Taiju Utsugisawa, MD, PhD2*, Satoru Miyano, MD, Ph.D.3*, Seishi Ogawa, MD, Ph.D.4, Seiji Kojima, MD, PhD5*, Shouichi Ohga, MD. PhD6*, Narla Mohandas, DSc7 and Hitoshi Kanno, MD, PhD2,8*

1Dept. Biochemistry, Tokyo Women's Medical University, Tokyo, Japan
2Dept. Transfusion Medicine and Cell Processing, Tokyo Women's Medical University, Tokyo, Japan
3Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
6Department of Pediatrics, Yamaguchi University, Ube, Japan
7New York Blood Center, New York, NY
8Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Graduate School of Medicine, Tokyo Women's Medical University, Tokyo, Japan

Immacolata Andolfo1*, Roberta Russo1*, Francesco Manna1*, Marica Lisa Salve1*, Alok K. Sharma2*, Seth L. Alper2*, Lucia De Franceschi, MD3 and Achille Iolascon, MD, PhD4

1CEINGE, Biotecnologie Avanzate, Naples, Italy, Department of Molecular Medicine and Medical Biotechnologies, “Federico II” University of Naples, Naples, Italy, Napoli, Italy
2Renal Division and Vascular Biology Research Center, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA., Boston, MA
3Department of Medicine, University of Verona and AOUI-Verona, Verona, Italy
4Department of Molecular Medicine and Medical Biotechnologies, “Federico II” University of Naples, Naples, Italy

Antonino Giambona1*, Gianfranca Damiani2*, Filippo Leto1*, Cristina Yakil2*, Cristina Passarello1*, Valentina Cigna2*, Giovanna Schillaci2*, Massimiliano Sacco1*, Rosario Di Maggio1*, Angela Vitrano1* and Aurelio Maggio1

1Campus of Haematology Franco e Piera Cutino- A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy
2U.O.S. Prenatal Diagnosis, Campus of Haematology Franco e Piera Cutino- A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy

Hongyu Wu, PhD1*, Mikhail Bogdanov, PhD2*, Yujin Zhang, MD3*, Kaiqi Sun, BS3,4, Anren Song, PhD2*, Hong Liu, MD3*, Morayo G, Adebiyi2*, Danny C. Alexander5*, Michael V. Milburn5*, Modupe Idowu, MD6, Harinder S. Juneja, MD6 and Yang Xia, MD, Ph.D4,7

1Univeristy of Texas-Medical School, Houston, TX
2University of Texas-Medical School, Houston, TX
3Department of Biochemistry and Molecular Biology, UTHSC-Houston Medical School, Houston, TX
4University of Texas Graduate School of Biomedical Science, Houston, TX
53Metabolon, Inc.,, Durham, NC
6Department of Internal Medicine-Hematology Division, University of Texas Health Science Center at Houston, Houston, TX
7Department of Biochemistry and Molecular Biology, University of Texas Medical School at Houston, Houston, TX

Eliza B Geer, MD1*, Lilian Varricchio, PhD2*, Fabrizio Martelli, PhD3*, Wu He, PhD4*, Lizette Couto5*, Yelena Lazar6*, Vanessa Cohen6* and Anna Rita Migliaccio, PhD2

1Mount Sinai Pituitary Care and Research Center, Icahn School of Medicine at Mount Sinai, New York, NY
2Tish Cancer Institute, Mount Sinai School of Medicine, New York, NY
3National AIDS Center, Istituto Superiore Di Sanita', Rome, Italy
4Icahn School of Medicine at Mount Sinai, Flow Cytometry Shared Resource Facility, New York, NY
5Department of Medicine & Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY
6Icahn School of Medicine at Mount Sinai, New York, NY

Rachael F. Grace, MD1, D Holmes Morton, MD2*, Wilma Barcellini, MD3*, Stefan W. Eber, MD4, Jenny M Depsotovic, DO5*, Christine M. Knoll, MD6, Hassan M. Yaish, MD7*, Peter E. Newburger, MD8, Jennifer Rothman, MD9, Alexis A. Thompson, MD10, Yaddanapudi Ravindranath, MBBS11, Joachim Kunz, MD12*, Eduard J van Beers, MD, PhD13*, Marcin W Wlodarski, MD14*, Kerri A Nottage, MD, MPH15, Heng Wang, MD16*, Mukta Sharma, MD, MPH17, Melissa J. Rose, DO18, Yves D. Pastore, MD19, Patricia J. Giardina, MD20, Melissa Rhodes, MD21, Kevin Kuo, BSc, MD22, Vicky R. Breakey, BSc, MD, MEd, FRCPC23, Ellis J. Neufeld, MD, PhD1, Dongjing Guo, MS1*, Wendy B. London, PhD1*, Jill Falcone1* and Bertil Glader, MD, PhD24

1Harvard Medical School, Dana Farber Boston Children’s Cancer and Blood Disorder Center, Boston, MA
2Lancaster General Hospital, Clinic for Special Children, Lancaster, PA
3Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
4Schwerpunktpraxis für Pädiatrische Hämatologie- Onkologie and Technical University, Munich, Germany
5Baylor College of Medicine, Texas Children’s Hematology Center, Houston, TX
6Phoenix Children's Hospital, Phoenix, AZ
7Primary Children’s Hospital, University of Utah, Salt Lake City, UT
8University of Massachusetts Medical School, Worcester, MA
9Duke University Medical Center, Durham, NC
10Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
11Wayne State University School of Medicine, Children’s Hospital of Michigan, Detroit, MI
12Heidelberg University, Heidelberg, Germany
13Van Creveldkliniek, University Medical Center, Utrecht, Netherlands
14University Children´s Hospital Freiburg, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany
15St. Jude Children's Research Hospital, Memphis, TN
16DDC Clinic for Special Needs Children, Middlefield, OH
17Children's Mercy Hospital, Kansas City, MO
18The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, OH
19CHU Sainte-Justine, Montreal, QC, Canada
20Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
21University of Mississippi Medical Center, Jackson, MS
22University of Toronto, University Health Network, Ontario, Canada
23Department of Pediatrics, McMaster University, Hamilton, ON, Canada
24Stanford University, Lucile Packard Children’s Hospital, Palo Alto, CA

Antonio M Risitano, MD, PhD1, Michael Storek2*, Leonardo Sahelijo, MD2*, Mittie Doyle2*, Yang Dai2*, Ilene Ceil Weitz, MD3, Judith C.W. Marsh, MD4, Modupe Elebute, MBChB, MD5*, Casey L O'Connell, MD6, Austin G. Kulasekararaj, MBBS, MD, MRCP, FRCPath7*, Giridharan Ramsingh, M.D8, Serena Marotta, MD1*, Andrzej Hellmann9 and Ante S. Lundberg, MD2

1Hematology, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
2Alexion Pharmaceuticals, Inc., Cheshire, CT
3Jane Anne Nohl Division of Hematology, University of Southern California-Keck School of Medicine, Los Angeles, CA
4King's College Hospital NHS Foundation Trust, London, United Kingdom
5Department of Haematology, King's College Hospital, London, United Kingdom
6Norris Comprehensive Cancer Center, Jane Anne Nohl Division of Hematology, University of Southern California, Los Angeles, CA
7Department of Haematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom
8Hematology, University of Southern California, Los Angeles, CA
9Department of Hematology, Medical University of Gdansk, Gdansk, Poland

Yasutaka Ueda, MD, PhD1, Makiko Osato, DS1*, Wynne Weston-Davies, MB FRCS2*, Miles A Nunn, DPhil2*, Satoru Hayashi1*, Jun-Ichi Nishimura, MD, PhD1 and Yuzuru Kanakura, MD, PhD1

1Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
2Volution Immuno Pharmaceuticals (UK) Ltd, London, United Kingdom

Marta Subías-Hidalgo, PhD1*, Alicia Lopez, PhD1*, Jaouad Anter, PhD1*, Sheila Pinto, PhD1*, Emilio Ojeda, MD2*, Jose A Garcia-Marco, MD, PhD2, Fernando Ataulfo Gonzalez-Fernandez, MD3*, Rafael Fores, MD2*, Laura Llorente, MD2*, Ana Maria Villegas-Martinez, MD3* and Santiago Rodriguez-Cordoba, MD1*

1Centro de Investigaciones Biológicas, CSIC. Madrid, Spain., Patología Molecular/Biologica del Complemento, Madrid, Spain
2Hematology, University Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain
3Hematology, Hospital Clínico San Carlos. Madrid, Spain, Madrid, Spain

Jennifer L Oliveira, MD1, Lori A Frederick, BS2*, Lea M Coon, MS1*, Molly Susan Hein, BS1*, Mrinal M Patnaik, MBBS3, Ayalew Tefferi, MD4, Animesh Pardanani, MBBS, PhD5, Stefan K Grebe, M.D., Ph.D.6*, David S Viswanatha, MD2 and James D Hoyer, MD1

1Hematopathology and Metabolic Hematology Laboratory, Mayo Clinic, Rochester, MN
2Hematopathology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
6Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Angela Vitrano1*, Giuseppina Calvaruso1*, Eliana Lai2*, Grazia Colletta3*, Alessandra Quota4*, Calogera Gerardi5*, Luciana Concetta Rigoli6*, Liana Cuccia7*, Francesco Gagliardotto8*, Aldo Filosa, MD9*, Vincenzo Caruso, MD10*, Crocetta Argento11*, Saveria Campisi12*, Michele Rizzo, MD13*, Carmelo Fidone14*, Paolo Rigano1*, Massimiliano Sacco1*, Alessia Pepe15*, Rosario Di Maggio1*, Lorella Pitrolo1* and Aurelio Maggio1

1Campus of Haematology Franco e Piera Cutino- A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy
22Dipartimento di Scienze Mediche, Sezione Talassemici Adulti, University of Cagliari, Cagliari, Italy
3Azienda Ospedaliera Univiversità Policlinico “Vittorio Emanuele -P.O. Ferrarotto, Catania, Italy
4Centro Microcitemia, A.O., Gela (CL), Italy
5A.O.O.C.R., Sciacca, Italy
6U.O. Genetica ed Immunologia Pediatrica, Policlinico “G. Martino”, Messina, Italy
7Unità Operativa Complessa Ematologia con Talassemia, ARNAS Civico, Palermo, Italy
8U.O.C. 7a Pediatria per le Emopatie Ereditarie, Centro di Prevenzione Diagnosi e Cura della Talassemia, A.O. “G. Di Cristina”, Palermo, Italy
9UOD Malattie rare del globulo rosso, AORN, Napoli, Italy
10Garibaldi Hospital, Catania, Italy
11U.O.S. di Talassemia, Ospedale San Giovanni di Dio, Agrigento, Italy
12Ospedale Umberto I, Siracusa, Italy
13Section of Hematology, A.O. Sant'Elia, Caltanissetta, Italy
14A.O.‘‘M. Paternò Arezzo’’, Ragusa, Italy
15CMR Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy

Veronica Agrigento*, Sclafani Serena*, Paolo Rigano*, Rita Barone*, Giuseppina Calvaruso*, Rosario Di Maggio*, Massimiliano Sacco*, Lorella Pitrolo*, Angela Vitrano*, Aurelio Maggio and Elena D'Alcamo*

Campus of Haematology Franco e Piera Cutino- A.O.O.R. “Villa Sofia-Cervello”, Palermo, Italy

Tamara K Moyo, MD, PhD1, Anass Bouchnita, MS2*, Nathalie Eymard, PhD2*, Vitaly Volpert, PhD2* and Mark J. Koury, MD1

1Division of Hematology/Oncology, Vanderbilt University, Nashville, TN
2Institut Camille Jordan, University Lyon 1, Villeurbanne, France

*signifies non-member of ASH